I would be overstepping my professional boundaries to discuss this further in this environment
Poor health outcomes in infants with vitamin B 12 deficiency include anemia, abnormal skin and hair development, convulsions, weak muscle tone, failure to thrive, mental developmental delay, and potentially abnormal movements.[4-8] Well-recognized at risk groups are exclusively breastfed infants of mothers with B 12 deficiency due to minimal or no dietary intake of animal products[9-21] or pernicious anemia caused by a maternal malabsorption of B 12 .[18,22] Infant vitamin B 12 status can be improved through maternal B 12 supplementation during pregnancy and lactation.[23-26] Deficient mothers who miss the opportunity to supplement during pregnancy should still be encouraged to supplement during early lactation since infant vitamin B 12 status correlates with milk vitamin B 12 levels in breastfed infants up to 6 months of age.[27-30] Although there are cases reported of exclusively breastfed infants with vitamin B 12 deficiency having biochemical and clinical improvement through adequate maternal supplementation alone,[9] direct supplementation of the infant is recommended when such treatments are available.[31-33] Drug Levels Methylcobalamin is the major form of vitamin B 12 in milk
A type II RAF kinase blocker, Ojemda works by binding a key player in the MAPK signaling cascade, disrupting the tumor cells unchecked growth and proliferation and triggering cell death
It arises from a combination of endocrine, inflammatory, neural, and intracellular mechanisms (Tong et al., 2022) and is linked to lifestyle factors, including diet (Bruckner et al., 2024)
Additional research has demonstrated that correcting vitamin D deficiency can, in itself, increase glutathione levels, and vice versa
Supports research into tissue repair and angiogenesis research
